CN111264737A - Sleep-aiding probiotic solid beverage and preparation method thereof - Google Patents
Sleep-aiding probiotic solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN111264737A CN111264737A CN202010216552.1A CN202010216552A CN111264737A CN 111264737 A CN111264737 A CN 111264737A CN 202010216552 A CN202010216552 A CN 202010216552A CN 111264737 A CN111264737 A CN 111264737A
- Authority
- CN
- China
- Prior art keywords
- sleep
- solid beverage
- aiding
- probiotic solid
- probiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 34
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 34
- 235000013361 beverage Nutrition 0.000 title claims abstract description 22
- 239000007787 solid Substances 0.000 title claims abstract description 22
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 6
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 49
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 23
- 229940026510 theanine Drugs 0.000 claims abstract description 23
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 17
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 14
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 14
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 14
- 241000186840 Lactobacillus fermentum Species 0.000 claims abstract description 14
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 14
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 14
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 14
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 14
- 235000021014 blueberries Nutrition 0.000 claims abstract description 14
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 14
- 229940012969 lactobacillus fermentum Drugs 0.000 claims abstract description 14
- 229930189775 mogroside Natural products 0.000 claims abstract description 13
- 239000004375 Dextrin Substances 0.000 claims abstract description 12
- 229920001353 Dextrin Polymers 0.000 claims abstract description 12
- 235000019425 dextrin Nutrition 0.000 claims abstract description 12
- 239000000832 lactitol Substances 0.000 claims abstract description 12
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims abstract description 12
- 235000010448 lactitol Nutrition 0.000 claims abstract description 12
- 229960003451 lactitol Drugs 0.000 claims abstract description 12
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 12
- 239000004386 Erythritol Substances 0.000 claims abstract description 11
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940009714 erythritol Drugs 0.000 claims abstract description 11
- 235000019414 erythritol Nutrition 0.000 claims abstract description 11
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 4
- 230000000694 effects Effects 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 8
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 241001052560 Thallis Species 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000011068 loading method Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000003223 protective agent Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 6
- 244000269722 Thea sinensis Species 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 4
- 208000019901 Anxiety disease Diseases 0.000 abstract description 3
- 230000036506 anxiety Effects 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 206010062519 Poor quality sleep Diseases 0.000 abstract description 2
- 230000007413 intestinal health Effects 0.000 abstract description 2
- 238000007580 dry-mixing Methods 0.000 abstract 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 241000186685 Lactobacillus hilgardii Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- -1 amide compounds Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a sleep-aiding probiotic solid beverage and a preparation method thereof in the field of food processing, wherein the sleep-aiding probiotic solid beverage is composed of gamma-aminobutyric acid, theanine, blueberry powder, mogroside, erythritol, probiotics and prebiotics; the probiotics comprise Bifidobacterium lactis, Lactobacillus acidophilus and Lactobacillus fermentum; prebiotics include fructo-oligosaccharides, resistant dextrins, and lactitol; the aseptic dry mixing process under the conditions of low temperature and low humidity is adopted, the raw materials are natural, the formula is scientific, the taste is fresh and cool, the aseptic dry mixing process is used for producing solid beverages, the aseptic dry mixing process can be directly eaten, can be taken with warm water, and is suitable for various crowds, particularly crowds with poor sleep, anxiety and the like. Through the combined use of the gamma-aminobutyric acid, the theanine and the blueberry powder and various prebiotics probiotics, the planting and proliferation of the ingested probiotics can be guaranteed, the intestinal health is protected, the sleep improvement requirement can be met, the anxiety is relieved, and the health-care tea is safe, mild and free of dependence.
Description
Technical Field
The invention relates to a sleep-aiding probiotic solid beverage and a preparation method thereof, belonging to the field of food processing.
Background
With the economic development and the improvement of living standard, people pay more and more attention to self health problems. The fast-paced life pattern in the city causes the problems of excessive mental stress, neurasthenia, anxiety, poor sleep quality and the like of many people. According to market data, the overall sleep-aiding market scale reaches 3203 hundred million yuan in 2018 in China, but related products using homology of medicine and food as sleep-aiding diet are not developed rapidly. According to the research report of 2018-2023 Chinese sleep medical market analysis and investment prospect published by Bosi data, the market scale of 2017 Chinese sleep improvement industry is about 2797 million yuan, wherein the sleep food and the health care products are only 128 million, and the sleep market of China is improved by using the sleep-aid food, so that the market still has a large market space.
Gamma-aminobutyric acid (GABA) is a naturally occurring non-protein amino acid, widely distributed and present in the bodies of animals and plants, and is also an important inhibitory neurotransmitter in the central nervous system of mammals, and about 30% of central nervous synapse sites use GABA as a transmitter to promote cerebral blood circulation and oxygen supply, play an important role in the cerebral cortex, hippocampus, thalamus, basal ganglia and cerebellum of the human body, and have a regulating effect on various functions of the body, relieve brain tension, and promote good sleep and growth hormone synthesis.
Theanine (L-Theanine) is a major amino acid present in tea leaves. The chemical designation of theanine is: N-ethyl-L-glutamine belongs to amide compounds, naturally-occurring theanine is L-type, and the grade of tea is higher when the content of theanine is higher. Theanine is very soluble in water and has sweet taste. The theanine has stable property, and can be boiled for 5 min or dissolved in pH 3 solution and stored at 25 deg.C for 12 months without change of theanine content, so that the properties of theanine can not be changed in the conventional food processing and sterilizing process. Has effects in regulating mood, tranquilizing mind, relieving fatigue, protecting nerve, and improving memory.
The anthocyanin in the blueberry has the effects of penetrating into cells to protect cell membranes from being oxidized by free radicals, has strong oxidation resistance and antiallergic functions, can penetrate through blood brain barriers, can protect cranial nerves from being oxidized, can stabilize brain tissue functions, and protects brains from being damaged by harmful chemical substances and toxins, so that the sleep quality is thoroughly improved.
Mogroside (or mogroside) is extracted from fructus Siraitiae Grosvenorii, which is a natural plant, has sweetness 300 times of sucrose and zero heat, has effects of clearing heat, moistening lung, relieving cough, loosening bowel to relieve constipation, and can be used for preventing and treating obesity, constipation, diabetes, etc.
Prebiotics are non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and activity of beneficial bacteria, thereby improving host health. The prebiotics enter the human body and mainly play the following roles: can effectively promote the reproduction and growth of bifidobacteria in intestinal tract; organic acid is generated due to fermentation, the pH value in the intestinal tract is reduced, the active transportation and passive transportation functions of intestinal epithelial cells are enhanced, and the effect of promoting mineral absorption is remarkable; after a certain amount of oligosaccharide prebiotics are taken, the prebiotics can regulate the lipid metabolism of the organism; has strong immunostimulating effect, and can enhance macrophage activity to generate antibiotic, and further stimulate lymphocyte to divide and reproduce continuously.
Probiotics is a kind of active microorganisms beneficial to a host, and is a general term for active beneficial microorganisms which are planted in the intestinal tract and the reproductive system of a human body and can generate definite health efficacy so as to improve the microbial ecological balance of the host and exert beneficial effects on the intestinal tract.
The solid beverage is prepared into powder, granules or blocks by processing food raw and auxiliary materials, food additives and the like, and is popular with consumers due to various varieties, convenient preparation, easy storage and carrying.
In recent years, probiotics products and sleep-aid products are hot spots, but few products are formed by combining probiotics with sleep-aid products, and the sleep-aid probiotics solid beverage can meet the requirements of people on intestinal health and sleep improvement. Therefore, it is necessary to develop a sleep-aiding product which is safe, mild and convenient and portable and does not produce dependency.
Disclosure of Invention
The invention aims to ensure the colonization and proliferation after the intake of probiotics and protect the health of intestinal tracts by combining the gamma-aminobutyric acid, theanine and blueberry powder with a plurality of prebiotics probiotics, and the health-care food is safe, mild and free of dependence and can meet the requirement of improving sleep.
In order to achieve the purpose, the invention is realized by the following technical scheme:
a sleep-aiding probiotic solid beverage is characterized in that: the solid beverage consists of gamma-aminobutyric acid, theanine, blueberry powder, mogroside, erythritol, probiotics and prebiotics; the probiotics comprise Bifidobacterium lactis, Lactobacillus acidophilus and Lactobacillus fermentum; prebiotics include fructo-oligosaccharides, resistant dextrins, and lactitol;
the technical scheme is further explained as follows: the sleep-aiding probiotic solid beverage comprises the following components in percentage by weight: 5-10% of gamma-aminobutyric acid, 3-8% of theanine, 10-30% of blueberry powder, 0.1-1% of mogroside, 5-20% of erythritol, 5-20% of fructo-oligosaccharide, 10-30% of resistant dextrin, 5-15% of lactitol, 0.5-3% of bifidobacterium lactis, 0.5-3% of lactobacillus acidophilus and 0.5-3% of lactobacillus fermentum;
the technical scheme is further explained as follows: the number of the live bacteria of the probiotics is as follows: bifidobacterium lactis 1X 1011-3×1011CFU/g, Lactobacillus acidophilus 1X 1011-2×1011CFU/g, Lactobacillus fermentum 1X 1011-4×1011CFU/g；
The technical scheme is further explained as follows: the sleep-aiding probiotic solid beverage has the water content of not more than 5 percent and the water activity of 0.15-0.2.
The preparation method of the sleep-aiding probiotic solid beverage comprises the following steps:
1) selecting a single strain frozen in a glycerol tube, purifying, performing expansion culture, performing high-density culture in a fermentation tank, centrifuging to obtain thalli, mixing the thalli with a protective agent, and performing vacuum freeze drying to obtain bifidobacterium lactis freeze-dried powder, lactobacillus acidophilus freeze-dried powder and lactobacillus fermentum freeze-dried powder;
2) uniformly mixing various bacteria with gamma-aminobutyric acid, theanine, blueberry powder, mogroside, erythritol, fructo-oligosaccharide, resistant dextrin and lactitol in proportion, sieving with a 80-mesh sieve, and packaging the mixed powder;
3) and (5) loading the small packages into a large box according to the specification requirement, inspecting, boxing and warehousing.
The invention has the following beneficial effects:
1. the lactobacillus such as bifidobacterium lactis and lactobacillus acidophilus used in the invention is physiological resident bacteria in human intestinal tracts, participates in metabolism of a plurality of organisms such as sugar, fat and the like, generates organic acid, short-chain fatty acid and the like, can regulate the internal environment of the organisms and has the function of benefiting life. The lactobacillus fermentum can promote the decomposition and transformation of cholesterol and effectively reduce blood fat. Fructooligosaccharides are derived from plants and lactitol is stable in the mouth, stomach and small intestine and is not substantially digested and absorbed. When entering the large intestine, it is easily decomposed by microbial fermentation. The resistant dextrin is low molecular dietary fiber processed by using starch as a raw material, has good water absorption, can keep the wetness of excrement and certain osmotic pressure, and can promote the proliferation of bifidobacteria, lactobacilli and the like.
2. The gamma-aminobutyric acid is produced by taking L-sodium glutamate as a raw material and performing the steps of lactobacillus hilgardii fermentation, heating sterilization, cooling, activated carbon treatment, filtering, adding a blending auxiliary material (starch), spray drying and the like, has the effects of inhibiting nerve excitation conduction, relaxing the body and mind and promoting sleep through nerve regulation, and is safe, mild and free of dependence. Theanine is a main amino acid in tea leaves, is natural and safe, so that the properties of the theanine are not changed in the common food processing and sterilization processes. Has effects in regulating mood, tranquilizing mind, relieving fatigue, protecting nerve, and improving memory.
Detailed Description
The invention is further illustrated by the following examples:
example 1
0.3g of gamma-aminobutyric acid, 0.3g of theanine, 1g of blueberry powder, 0.05g of mogroside, 0.5g of erythritol, 1g of fructo-oligosaccharide, 1g of resistant dextrin, 0.5g of lactitol, 0.1g of bifidobacterium lactis, 0.1g of lactobacillus acidophilus and 0.15g of lactobacillus fermentum, wherein the total amount of each part is 5 g.
Example 2
0.5g of gamma-aminobutyric acid, 0.4g of theanine, 0.9g of blueberry powder, 0.05g of mogroside, 0.8g of erythritol, 0.5g of fructo-oligosaccharide, 0.5g of resistant dextrin, 1g of lactitol, 0.15g of bifidobacterium lactis, 0.1g of lactobacillus acidophilus and 0.1g of lactobacillus fermentum, wherein the total amount of each part is 5 g.
Example 3
0.2g of gamma-aminobutyric acid, 0.15g of theanine, 1.1g of blueberry powder, 0.05g of mogroside, 0.7g of erythritol, 1.5g of fructo-oligosaccharide, 0.5g of resistant dextrin, 0.4g of lactitol, 0.15g of bifidobacterium lactis, 0.15g of lactobacillus acidophilus and 0.1g of lactobacillus fermentum, wherein the total amount of each part is 5 g.
The sleep-aiding probiotic solid beverage disclosed by the embodiments 1 to 3 of the invention is prepared by the following processes:
1) selecting a single strain frozen in a glycerol tube, purifying, performing expansion culture, performing high-density culture in a fermentation tank, centrifuging to obtain thalli, mixing the thalli with a protective agent, and performing vacuum freeze drying to obtain bifidobacterium lactis freeze-dried powder, lactobacillus acidophilus freeze-dried powder and lactobacillus fermentum freeze-dried powder;
2) uniformly mixing various bacteria with gamma-aminobutyric acid, theanine, blueberry powder, mogroside, erythritol, fructo-oligosaccharide, resistant dextrin and lactitol in proportion, sieving with a 80-mesh sieve, and packaging the mixed powder;
3) and (5) loading the small packages into a large box according to the specification requirement, inspecting, boxing and warehousing.
Claims (5)
1. A sleep-aiding probiotic solid beverage is characterized in that: the sleep-aiding probiotic solid beverage consists of gamma-aminobutyric acid, theanine, blueberry powder, mogroside, erythritol, probiotics and prebiotics; the probiotics comprise Bifidobacterium lactis, Lactobacillus acidophilus and Lactobacillus fermentum; prebiotics include fructooligosaccharides, resistant dextrins, and lactitol.
2. The sleep-aid probiotic solid beverage according to claim 1, characterized in that: the sleep-aiding probiotic solid beverage comprises the following components in percentage by weight: 5-10% of gamma-aminobutyric acid, 3-8% of theanine, 10-30% of blueberry powder, 0.1-1% of mogroside, 5-20% of erythritol, 5-20% of fructo-oligosaccharide, 10-30% of resistant dextrin, 5-15% of lactitol, 0.5-3% of bifidobacterium lactis, 0.5-3% of lactobacillus acidophilus and 0.5-3% of lactobacillus fermentum.
3. The sleep-aid probiotic solid beverage according to claim 1, characterized in that: the number of the live bacteria of the probiotics is as follows: bifidobacterium lactis 1X 1011-3×1011CFU/g, Lactobacillus acidophilus 1X 1011-2×1011CFU/g, Lactobacillus fermentum 1X 1011-4×1011CFU/g。
4. A method for preparing the sleep-aiding probiotic solid beverage as claimed in claim 1, which is characterized in that: the method comprises the following steps:
1) selecting a single strain frozen in a glycerol tube, purifying, performing expansion culture, performing high-density culture in a fermentation tank, centrifuging to obtain thalli, mixing the thalli with a protective agent, and performing vacuum freeze drying to obtain bifidobacterium lactis freeze-dried powder, lactobacillus acidophilus freeze-dried powder and lactobacillus fermentum freeze-dried powder;
2) uniformly mixing various bacteria with gamma-aminobutyric acid, theanine, blueberry powder, mogroside, erythritol, fructo-oligosaccharide, resistant dextrin and lactitol in proportion, sieving with a 80-mesh sieve, and packaging the mixed powder;
3) and (5) loading the small packages into a large box according to the specification requirement, inspecting, boxing and warehousing.
5. The sleep-aid probiotic solid beverage according to claims 1 to 4, characterized in that the moisture content of the sleep-aid probiotic solid beverage is not more than 5%, and the water activity is between 0.15 and 0.2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010216552.1A CN111264737A (en) | 2020-03-25 | 2020-03-25 | Sleep-aiding probiotic solid beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010216552.1A CN111264737A (en) | 2020-03-25 | 2020-03-25 | Sleep-aiding probiotic solid beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111264737A true CN111264737A (en) | 2020-06-12 |
Family
ID=70991776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010216552.1A Pending CN111264737A (en) | 2020-03-25 | 2020-03-25 | Sleep-aiding probiotic solid beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111264737A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112568397A (en) * | 2020-12-04 | 2021-03-30 | 浙江蓝美生物技术有限公司 | Blueberry powder compound solid preparation capable of improving sleep and preparation method and application thereof |
| CN113208023A (en) * | 2021-05-22 | 2021-08-06 | 厦门市燕之屋丝浓食品有限公司 | Sleep-aiding cubilose beverage and preparation method thereof |
| CN113854457A (en) * | 2021-09-18 | 2021-12-31 | 山东绿丰生态农业股份有限公司 | Cherry enzyme solid beverage capable of helping sleep and promoting digestion and preparation method thereof |
| CN113995139A (en) * | 2021-10-28 | 2022-02-01 | 驻马店华中正大有限公司 | Probiotic composition and application thereof |
| CN115226773A (en) * | 2022-06-29 | 2022-10-25 | 湖北明慧健康科技有限责任公司 | Composite probiotic sleep-aiding solid beverage and preparation method thereof |
| CN115474660A (en) * | 2021-05-31 | 2022-12-16 | 海南三圣堂生物科技有限公司 | Anti-aging sleep-aiding noni enzyme formula and preparation method thereof |
| CN115521883A (en) * | 2022-02-16 | 2022-12-27 | 广东益可维生物技术有限公司 | Probiotics with functions of relieving pressure and improving sleep |
| CN116058455A (en) * | 2023-02-13 | 2023-05-05 | 重庆瑞航生物科技有限公司 | Blueberry beverage capable of promoting sleep and preparation method thereof |
| CN116098255A (en) * | 2022-12-28 | 2023-05-12 | 民强(昆山)食品科技有限公司 | Beverage before sleeping and preparation method thereof |
| JP7429076B1 (en) | 2023-04-04 | 2024-02-07 | ウィステリア製薬株式会社 | Powder containing lactic acid bacteria, disinfectant, oral care agent |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105029417A (en) * | 2015-08-26 | 2015-11-11 | 苏州泽达兴邦医药科技有限公司 | Health food used for improving sleeping quality and production process thereof |
| CN109329419A (en) * | 2018-08-28 | 2019-02-15 | 吉林标普生物科技有限公司 | A kind of functional probiotics solid beverage and preparation method thereof for being able to maintain that intestinal health and improving immunity |
| CN109770148A (en) * | 2019-03-12 | 2019-05-21 | 上海昊岳食品科技有限公司 | A kind of instant type probiotics solid beverage and preparation method thereof |
-
2020
- 2020-03-25 CN CN202010216552.1A patent/CN111264737A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105029417A (en) * | 2015-08-26 | 2015-11-11 | 苏州泽达兴邦医药科技有限公司 | Health food used for improving sleeping quality and production process thereof |
| CN109329419A (en) * | 2018-08-28 | 2019-02-15 | 吉林标普生物科技有限公司 | A kind of functional probiotics solid beverage and preparation method thereof for being able to maintain that intestinal health and improving immunity |
| CN109770148A (en) * | 2019-03-12 | 2019-05-21 | 上海昊岳食品科技有限公司 | A kind of instant type probiotics solid beverage and preparation method thereof |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112568397A (en) * | 2020-12-04 | 2021-03-30 | 浙江蓝美生物技术有限公司 | Blueberry powder compound solid preparation capable of improving sleep and preparation method and application thereof |
| CN113208023A (en) * | 2021-05-22 | 2021-08-06 | 厦门市燕之屋丝浓食品有限公司 | Sleep-aiding cubilose beverage and preparation method thereof |
| CN115474660A (en) * | 2021-05-31 | 2022-12-16 | 海南三圣堂生物科技有限公司 | Anti-aging sleep-aiding noni enzyme formula and preparation method thereof |
| CN113854457A (en) * | 2021-09-18 | 2021-12-31 | 山东绿丰生态农业股份有限公司 | Cherry enzyme solid beverage capable of helping sleep and promoting digestion and preparation method thereof |
| CN113995139A (en) * | 2021-10-28 | 2022-02-01 | 驻马店华中正大有限公司 | Probiotic composition and application thereof |
| CN115521883A (en) * | 2022-02-16 | 2022-12-27 | 广东益可维生物技术有限公司 | Probiotics with functions of relieving pressure and improving sleep |
| CN115521883B (en) * | 2022-02-16 | 2024-02-20 | 广东益可维生物技术有限公司 | Probiotics with pressure relieving and sleep improving functions |
| CN115226773A (en) * | 2022-06-29 | 2022-10-25 | 湖北明慧健康科技有限责任公司 | Composite probiotic sleep-aiding solid beverage and preparation method thereof |
| CN116098255A (en) * | 2022-12-28 | 2023-05-12 | 民强(昆山)食品科技有限公司 | Beverage before sleeping and preparation method thereof |
| CN116058455A (en) * | 2023-02-13 | 2023-05-05 | 重庆瑞航生物科技有限公司 | Blueberry beverage capable of promoting sleep and preparation method thereof |
| JP7429076B1 (en) | 2023-04-04 | 2024-02-07 | ウィステリア製薬株式会社 | Powder containing lactic acid bacteria, disinfectant, oral care agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111264737A (en) | Sleep-aiding probiotic solid beverage and preparation method thereof | |
| CN111728111B (en) | Probiotic composition for relieving anxiety or depression and application thereof | |
| CN106619743A (en) | Probiotic solid drink with hypoglycaemic effect and preparation method of probiotic solid drink | |
| CN106798252B (en) | Natto product with effects of regulating intestines and stomach, reducing blood fat and dissolving thrombus | |
| CN104305207B (en) | The formula of a kind of Chinese medicine composite enzyme and its preparation method | |
| CN107568537A (en) | A kind of compound microorganism ferments beverage containing anthocyanidin and preparation method thereof | |
| CN111557404A (en) | Digestion-aiding probiotic solid beverage and preparation method thereof | |
| CN103766904A (en) | Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule | |
| CN106165780A (en) | A kind of broiler Chinese medicine composite probiotics feed additive and preparation method thereof | |
| CN108685006A (en) | A kind of 3 solid beverage of omega | |
| CN112167623A (en) | Method for improving efficacy of animal and plant raw material traditional Chinese medicine enzyme by using fermentation technology | |
| CN105962378A (en) | Preparation method of active lactobacillus preparation containing hericium polysaccharides | |
| CN106389784A (en) | Composition for clearing away lung-heat, moistening lung and enhancing immunity and application of composition | |
| CN114246222A (en) | Plant-based yoghourt with functions of calming nerves, helping sleep and improving gastrointestinal tract and preparation method thereof | |
| CN110664896B (en) | Anti-stress sudden death prevention compound fermentation traditional Chinese medicine additive and preparation method and application thereof | |
| CN113349377A (en) | Slimming probiotic soft capsule and preparation method thereof | |
| CN114176170B (en) | Functional feed additive and preparation method and application thereof | |
| CN105497106A (en) | Traditional Chinese medicine compound fermentation powder and preparation method thereof | |
| CN109925466A (en) | A kind of enteral microecological formulation and preparation method thereof adjusting man's diarrhea | |
| CN115486541B (en) | Herbal probiotic composition with whitening effect and preparation method thereof | |
| CN108660174B (en) | Sesame bioactive peptide for resisting fatigue and promoting intestinal probiotic proliferation | |
| CN115211508A (en) | Enzyme beverage and preparation method thereof | |
| CN114470084A (en) | Environment-friendly and efficient composition for preventing and treating white feces of tilapia mossambica as well as preparation method and application thereof | |
| CN108186941B (en) | Composition for promoting growth and fattening of livestock and poultry and preparation method thereof | |
| CN112971156A (en) | Grape leaf dietary fiber extract and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200612 |